French Regulator Advises Pulling Servier Drug From Market
This article is for subscribers only.
France’s drug regulator advised pulling a medication made by Les Laboratoires Servier to treat vertigo, eye diseases and tinnitus because it doesn’t work and has side effects.
Vastarel, which has the chemical name Trimetazidine, and generic versions don’t have “recognized benefits” for the treatment of three medical conditions and have “well-documented” side effects, Agence Francaise de Securite Sanitaire des Produits de Sante, or Afssaps, said in a statement on its website dated April 8.